Table 2. Primary Outcome (Abdominal Pain) ^a.

Variables (h)	Placebo Group	Bupivacaine Group	Ketorolac	P Value (Within Groups)
VAS 1	6.7 ± 0.9	5.8 ± 1.7	6.0 ± 1.0	< 0.001
VAS 6	4.9 ± 1.56	3.6 ± 1.3	4.5 ± 1.0
VAS 12	4.0 ± 1.1	2.6 ± 1.4	2.9 ± 1.6
VAS 18	2.5 ± 1.4	1.6 ± 1.5	1.6 ± 1.0
VAS 24	1.1 ± 1.4	0.7 ± 0.7	0.9 ± 0.9
P value (between groups)	0.001

Abbreviation: VAS, Visual Analog Scale (0 ‑ 10 cm).

^a Values are expressed as mean ± SD.